Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape
- Event date: October 10, 2018 1:00 pm - 2:00 pm
- Location: N/A
David Jackman from Dana-Farber will discuss how his team considers evidence, how clinicians make on- and off-pathway treatment decisions at the point of care, and how varying genomic alterations in a patient’s tumor can be married to a drive towards enhanced clinical quality and an appropriate reduction in variation of treatment decisions, while maintaining a granular and “personalized” view of each patient. Dr. Jackman will also review how Dana-Farber uses analytics and real-world evidence alongside clinical experience and published evidence in a continuous-learning framework.
- David Jackman, MD
- Louis Culot